Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IFT140 |
| Upstream (Parents) |
|---|
| (<<) HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI → IFT140 |
| (<<) ACYP1 → IFT140 |
| (<<) NPDC1 → IFT140 |
| (<<) AK2 → IFT140 |
| (<<) NACA2///NACAP1///NACA → IFT140 |
| Downstream (Children) |
|---|
| IFT140 → CDH6 (>>) |
| IFT140 → CXorf57 (>>) |
| IFT140 → ANKS1B (>>) |
| IFT140 → PFDN4 (>>) |
| IFT140 → CROCCL2 (>>) |
| IFT140 → FZD9 (>>) |
| IFT140 → MPP3 (>>) |
| IFT140 → CACNA1C (>>) |
| IFT140 → CUL7 (>>) |
| IFT140 → RASA4P///RASA4 (>>) |
| IFT140 → AGGF1 (>>) |
